Artificial Pancreas

Michael Quartuccio, M.D., Thomas Donner, M.D.

Artificial Pancreas is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

A COVID-19 Conversation - Variants, Vaccines, and Long-Term Effects

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

DEFINITION

An "artificial pancreas" generally refers to automated, closed-looped insulin-delivery systems for patients with diabetes. They generally are comprised of a continuous glucose monitor, continuous subcutaneous insulin infusion (insulin pump), and a processor with loaded algorithms to determine the dosage of insulin to deliver. Some systems are "bihormonal," containing both insulin and glucagon.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

DEFINITION

An "artificial pancreas" generally refers to automated, closed-looped insulin-delivery systems for patients with diabetes. They generally are comprised of a continuous glucose monitor, continuous subcutaneous insulin infusion (insulin pump), and a processor with loaded algorithms to determine the dosage of insulin to deliver. Some systems are "bihormonal," containing both insulin and glucagon.

There's more to see -- the rest of this entry is available only to subscribers.